Zyflamend sensitizes tumor cells to TRAIL-induced apoptosis through up-regulation of death receptors and down-regulation of survival proteins: role of ROS-dependent CCAAT/enhancer-binding protein-homologous protein pathway.

Kim, Ji Hye

Zyflamend sensitizes tumor cells to TRAIL-induced apoptosis through up-regulation of death receptors and down-regulation of survival proteins: role of ROS-dependent CCAAT/enhancer-binding protein-homologous protein pathway. [electronic resource] - Antioxidants & redox signaling Mar 2012 - 413-27 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1557-7716

10.1089/ars.2011.3982 doi


Apoptosis--drug effects
Cell Line, Tumor
Cell Survival--drug effects
Down-Regulation--drug effects
Humans
Plant Extracts--pharmacology
Reactive Oxygen Species--metabolism
Receptors, Death Domain--genetics
TNF-Related Apoptosis-Inducing Ligand--metabolism
Transcription Factor CHOP--metabolism
Up-Regulation--drug effects